ITM announces research awards tackling mental illness, cancer and more
The Institute for Translational Medicine (ITM) has named three award winners and selected 10 finalists for the next round of its research accelerator program that offers $60,000 and high-value resources to launch innovative projects.
The ITM has given researchers nearly $7 million in seed funding and hundreds of thousands of dollars in resources through its Pilot Award program to explore unique ideas and work with community and industry partners to turn those findings to real-world health improvement tools as soon as possible. Former Pilot Award winners have gone on to launch companies, secure millions of dollars in federal funding, create national programs and more.
The 2018 Pilot Award recipients include three UChicago investigators:
- Benjamin Shogan, MD - Preventing Cancer from Coming Back
- Jennifer Wildes, PhD - Building the First Blood Test to Diagnose and Treat Mental Illness
- Bakhtiar Yamini, MD, Using Altitude Sickness Pills to Better Treat Brain Cancer
Finalists advancing to the next round of the new funding cycle include six researchers from UChicago, and their projects involve collaborators across the ITM network and country.
Read more about the finalists and their projects from the ITM.
Institute for Translational Medicine
The Institute for Translational Medicine is a partnership between the University of Chicago and several Chicago-area academic and health care institutions that helps researchers, the public, government, industry, and nonprofits work together to improve the health of all Chicagoland.
Learn more about the ITM